NDC 75929-055 - Hyoscyamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 75929-055
- Package NDCs from labels
- 75929-055-10
- Manufacturer
- Pharma Packaging Solutions, LLC dba Tjoapack LLC | Sovereign Pharmaceuticals, LLC
- Effective date
- 2023-08-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hyoscyamine - Pharma Packaging Solutions, LLC dba Tjoapack LLC | Sovereign Pharmaceuticals, LLC | Pharma Packaging Solutions, LLC dba Tjoapack LLC | Sovereign Pharmaceuticals, LLC | 2023-08-02 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OSCIMIN | HYOSCYAMINE SULFATE | Larken Laboratories, Inc. | 2d5fa637-0696-40fe-9bc1-fcb6f07a50f6 | 2025-10-16 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate SL | HYOSCYAMINE SULFATE | Acella Pharmaceuticals, LLC | 8aab1dce-0699-4866-8707-33b4e2177bdd | 2025-10-02 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate TAB | HYOSCYAMINE SULFATE | Acella Pharmaceuticals, LLC | 49fe1783-ab0c-4adb-869b-384121cf7f05 | 2025-10-02 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | ANI Pharmaceuticals, Inc. | 3859133e-88bd-4dd5-90a0-82b64347f1db | 2025-09-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | ANI Pharmaceuticals, Inc. | 48fa3d71-8c78-4f29-b1f0-ecac8c36473e | 2025-09-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | ANI Pharmaceuticals, Inc. | cdb8f10a-b426-448f-8991-7724ffa88cb5 | 2025-09-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | ANI Pharmaceuticals, Inc. | 66fdfc33-a7b9-465b-84f1-012cdf5517fd | 2025-09-12 | Warnings, Adverse reactions | F2R8V82B84 |
| UROGESIC BLUE | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | EDWARDS PHARMACEUTICALS, INC. | d820e42d-ad2b-4e11-907b-a94d698ca285 | 2025-08-13 | Warnings, Adverse reactions | F2R8V82B84 |
| Levsin | HYOSCYAMINE SULFATE | Viatris Specialty LLC | 32388e18-08de-455c-aad4-9c2264435f0f | 2025-07-15 | Warnings, Adverse reactions | F2R8V82B84 |
| Levbid | HYOSCYAMINE SULFATE | Viatris Specialty LLC | eb13c96f-319a-46f4-9955-ef5fa0a5f110 | 2025-07-15 | Warnings, Adverse reactions | F2R8V82B84 |
| NuLev | HYOSCYAMINE SULFATE | Viatris Specialty LLC | ae2a78b2-b811-11e2-9e96-0800200c9a66 | 2025-07-15 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate TAB | HYOSCYAMINE SULFATE | Bryant Ranch Prepack | b8759036-81f9-4e31-8763-9e42cf78d9c5 | 2025-06-02 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Proficient Rx LP | 1f4b1ed7-bbba-4b2c-8139-b35cb428587d | 2025-06-01 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyosyne | HYOSCYAMINE SULFATE | ATLANTIC BIOLOGICALS CORP. | 08ee0b24-a05b-451c-9d29-975570baed48 | 2025-05-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyosyne | HYOSCYAMINE SULFATE | ATLANTIC BIOLOGICALS CORP. | d022cde6-90c7-48b5-8022-cf7b76f4da19 | 2025-05-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate SL | HYOSCYAMINE SULFATE | Westminster Pharmaceuticals, LLC | 2b7d1604-3e95-4fc9-a65d-2c06ace16009 | 2025-04-21 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Westminster Pharmaceuticals, LLC | 9c0ae67b-7887-4820-ad77-8ea7261f9ed3 | 2025-04-21 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate ODT | HYOSCYAMINE SULFATE | Westminster Pharmaceuticals, LLC | 9429898d-301f-4ebc-8b1d-60595f76f1e3 | 2025-04-09 | Warnings, Adverse reactions | F2R8V82B84 |
| MB CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | 2efeb281-b84b-4750-e063-6394a90a27ee | 2025-02-25 | Warnings, Adverse reactions | F2R8V82B84 |
| URIMAR-T CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | cf7c3d65-11d2-49cd-b207-8ccc6a221fe0 | 2025-01-08 | Warnings, Adverse reactions | F2R8V82B84 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.